Broker's take

TalkMed Group > Neutral RHB Securities, April 27 April 27 close: S$0.695 Target price: S$0.70

TalkMed Group reported a weak Q1 2018 . . . mainly owing to the the Singapore Medical Council's suspension of its key contributor and chief executive Ang Peng Tiam.

On the bright side, losses from associates have been reduced drastically by 60 per cent year on year, and it is expected to generate profits by end-FY2018.